$DMTKQ
DermTech Inc Stock $dmtkq

$dmtkq Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000165194424000014 Filed on February 29, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$3.845M	$3.924M	$15.30M
YoY Change	10.58%	31.06%	5.36%
Cost Of Revenue	$3.132M	$3.484M	$15.02M
YoY Change	-18.03%	4.0%	8.28%
Gross Profit	$713.0K	$440.0K	$276.0K
YoY Change	-307.27%	-223.6%	-57.34%
Gross Profit Margin	18.54%	11.21%	1.8%
Selling, General & Admin	$17.96M	$16.84M	$88.78M
YoY Change	-34.21%	-28.1%	-6.31%
% of Gross Profit	2518.23%	3828.18%	32165.22%
Research & Development	$3.266M	$3.348M	$15.24M
YoY Change	-25.92%	-34.31%	-36.64%
% of Gross Profit	458.06%	760.91%	5521.38%
Depreciation & Amortization	$490.0K	$442.0K	$1.800M
YoY Change	5.15%	-1.12%	12.5%
% of Gross Profit	68.72%	100.45%	652.17%
Operating Expenses	$21.22M	$20.19M	$104.0M
YoY Change	-33.06%	-29.21%	-12.45%
Operating Profit	-$20.51M	-$19.75M	-$103.7M
YoY Change	-36.0%	-31.6%	-12.21%
Interest Expense	$498.0K	$660.0K	$2.846M
YoY Change	-36.32%	2.96%	112.23%
% of Operating Profit
Other Income/Expense, Net	$498.0K	$1.000K	$2.851M
YoY Change	-35.74%	-93.33%	92.38%
Pretax Income	-$20.01M	-$19.09M	-$100.9M
YoY Change	-36.01%	-32.36%	-13.54%
Income Tax
% Of Pretax Income
Net Earnings	-$20.00M	-$19.09M	-$100.9M
YoY Change	-36.04%	-32.36%	-13.53%
Net Earnings / Revenue	-520.16%	-486.52%	-659.65%
Basic Earnings Per Share	-$0.58		-$3.09
Diluted Earnings Per Share	-$0.58	-$0.56	-$3.09
COMMON SHARES
Basic Shares Outstanding	34.62M shares	34.24M shares	32.64M shares
Diluted Shares Outstanding	34.71M shares		32.64M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$38.98M	$55.86M	$55.86M
YoY Change	-62.8%	-55.72%	-55.73%
Cash & Equivalents	$27.60M	$36.70M	$36.74M
Short-Term Investments	$11.40M	$19.12M	$19.12M
Other Short-Term Assets	$651.0K	$581.0K	$2.300M
YoY Change	-1.36%	-20.74%	-41.03%
Inventory	$831.0K	$1.004M	$1.004M
Prepaid Expenses
Receivables	$2.497M	$2.584M	$2.584M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$44.20M	$61.75M	$61.75M
YoY Change	-60.67%	-54.61%	-54.59%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.498M	$4.988M	$56.71M
YoY Change	-28.17%	-21.76%	-9.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.467M	$0.00	$3.468M
YoY Change	1963.69%	-100.0%	-6.27%
Total Long-Term Assets	$58.77M	$60.18M	$60.18M
YoY Change	-9.21%	-8.87%	-8.96%
TOTAL ASSETS
Total Short-Term Assets	$44.20M	$61.75M	$61.75M
Total Long-Term Assets	$58.77M	$60.18M	$60.18M
Total Assets	$103.0M	$121.9M	$121.9M
YoY Change	-41.86%	-39.66%	-39.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.913M	$1.484M	$1.484M
YoY Change	13.87%	-38.65%	-38.17%
Accrued Expenses	$1.943M	$2.017M	$11.75M
YoY Change	-59.58%	-41.77%	-9.62%
Deferred Revenue	$200.0K	$200.0K
YoY Change	0.0%	100.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$17.00K	$17.00K	$17.00K
YoY Change	-82.47%	-85.34%	-83.0%
Total Short-Term Liabilities	$12.52M	$13.45M	$13.45M
YoY Change	-22.43%	-14.0%	-13.8%
LONG-TERM LIABILITIES
Long-Term Debt	$34.00K	$38.00K	$38.00K
YoY Change	-30.61%	-28.3%	-62.0%
Other Long-Term Liabilities	$50.42M	$51.27M	$51.27M
YoY Change	-6.09%	-5.11%	-5.06%
Total Long-Term Liabilities	$50.46M	$51.31M	$51.31M
YoY Change	-6.11%	-5.14%	-5.16%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.52M	$13.45M	$13.45M
Total Long-Term Liabilities	$50.46M	$51.31M	$51.31M
Total Liabilities	$62.98M	$64.76M	$64.75M
YoY Change	-9.88%	-7.12%	-7.09%
SHAREHOLDERS EQUITY
Retained Earnings	-$443.9M	-$423.9M
YoY Change	25.29%	31.24%
Common Stock	$483.8M	$480.9M
YoY Change	4.74%	5.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$39.99M	$57.18M	$57.18M
YoY Change
Total Liabilities & Shareholders Equity	$103.0M	$121.9M	$121.9M
YoY Change	-41.86%	-39.66%	-39.67%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$20.00M	-$19.09M	-$100.9M
YoY Change	-36.04%	-32.36%	-13.53%
Depreciation, Depletion And Amortization	$490.0K	$442.0K	$1.800M
YoY Change	5.15%	-1.12%	12.5%
Cash From Operating Activities	-$17.10M	-$12.71M	-$77.00M
YoY Change	-22.37%	-40.15%	-19.17%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	-$163.0K	$902.0K
YoY Change	-100.0%	-108.43%	-72.71%
Acquisitions
YoY Change
Other Investing Activities	$7.834M	$12.08M	$30.77M
YoY Change	-205.34%	120.76%	-3134.12%
Cash From Investing Activities	$7.834M	$12.24M	$29.86M
YoY Change	-195.61%	245.95%	-791.46%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$5.248M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$122.0K	-24.00K	$6.079M
YoY Change	-86.68%	-27.27%	562.92%
NET CHANGE
Cash From Operating Activities	-$17.10M	-12.71M	-$77.00M
Cash From Investing Activities	$7.834M	12.24M	$29.86M
Cash From Financing Activities	$122.0K	-24.00K	$6.079M
Net Change In Cash	-$9.163M	-488.0K	-$41.04M
YoY Change	-68.73%	-97.25%	-58.41%
FREE CASH FLOW
Cash From Operating Activities	-$17.10M	-$12.71M	-$77.00M
Capital Expenditures	$0.00	-$163.0K	$902.0K
Free Cash Flow	-$17.10M	-$12.54M	-$77.90M
YoY Change	-24.95%	-45.84%	-20.96%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	13871000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	12000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	812000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	48411000	usd
CY2022Q4	dmtk	Estimated Market Value Of Debt Securities With Contractual Maturities Of Less Than12 Months EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months	40200000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6664000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7894000	usd
CY2022Q4	dmtk	Accrued Consulting Services Current AccruedConsultingServicesCurrent	894000	usd
CY2023Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	1008000	usd
CY2022Q4	us-gaap	Customer Refund Liability Current CustomerRefundLiabilityCurrent	980000	usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve	10000	usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	737000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1590000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2017000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3464000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001651944
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2019Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.5
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38118
CY2023	dei	Entity Registrant Name EntityRegistrantName	DERMTECH, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-2870849
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	12340 El Camino Real
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92130
CY2023	dei	City Area Code CityAreaCode	858
CY2023	dei	Local Phone Number LocalPhoneNumber	450‑4222
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2023	dei	Trading Symbol TradingSymbol	DMTK
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	85237006	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	34623443	shares
CY2023	dei	Auditor Firm AuditorFirmId	185
CY2023	dei	Auditor Name AuditorName	KPMG LLP
CY2023	dei	Auditor Location AuditorLocation	San Diego, CA
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36741000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	77757000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	19123000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	48411000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2584000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4172000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	1004000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1757000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2300000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3940000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	61752000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	136037000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4988000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6375000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	51722000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	56007000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3468000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3488000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	168000	usd
CY2023Q4	us-gaap	Assets Assets	121930000	usd
CY2022Q4	us-gaap	Assets Assets	202075000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1484000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2419000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6664000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7894000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2017000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3464000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	196000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	109000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3069000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1634000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	116000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13447000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15636000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	0	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	38000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	53000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	51270000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	54028000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	64755000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	69722000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34524677	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34524677	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30297408	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30297408	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	480929000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	456171000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	178000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-774000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-423935000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-323047000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	57175000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	132353000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	121930000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	202075000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15296000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	14518000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	15020000	usd
CY2023	us-gaap	Gross Profit GrossProfit	276000	usd
CY2022	us-gaap	Gross Profit GrossProfit	647000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	44995000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	58674000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15239000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	24052000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	43781000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36086000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	104015000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	118812000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-103739000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-118165000	usd
CY2023	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	2846000	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1341000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-141000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2851000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1482000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-100888000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-116683000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	34393000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32641376	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32641376	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30038959	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30038959	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.09
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.09
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.88
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.88
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-100888000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-116683000	usd
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	952000	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-650000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-99936000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-117333000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	229698000	usd
CY2022	dmtk	Stock Issued During Period Value Stock Options Exercised And Rsu Release StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease	40000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	22000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	992000	usd
CY2022	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-650000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18934000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-116683000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	132353000	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5248000	usd
CY2023	dmtk	Stock Issued During Period Value Stock Options Exercised And Rsu Release StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease	58000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	887000	usd
CY2023	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	952000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18565000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-100888000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	57175000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-100888000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-116683000	usd
CY2023	us-gaap	Depreciation Depreciation	1824000	usd
CY2022	us-gaap	Depreciation Depreciation	1634000	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-5000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-141000	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4022000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2826000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	18565000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	18934000	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	526000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-402000	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-18000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-324000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1588000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	325000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-753000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1277000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1808000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	774000	usd
CY2023	dmtk	Increase Decrease In Operating Lease Right Of Use Asset And Liability IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiability	-1060000	usd
CY2022	dmtk	Increase Decrease In Operating Lease Right Of Use Asset And Liability IncreaseDecreaseInOperatingLeaseRightOfUseAssetAndLiability	-3028000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1848000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1882000	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1230000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	966000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-76979000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-95260000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	31498000	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	65159000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	30484000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	902000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3305000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	29864000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4319000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5248000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	22000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	58000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	40000	usd
CY2023	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	887000	usd
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	992000	usd
CY2023	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	114000	usd
CY2022	us-gaap	Repayments Of Debt And Capital Lease Obligations RepaymentsOfDebtAndCapitalLeaseObligations	137000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6079000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	917000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-41036000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-98662000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	81245000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	179907000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	40209000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	81245000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36741000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	77757000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3468000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	3488000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40209000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	81245000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	5000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	13000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	431000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	51089000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	48000	usd
CY2023	dmtk	Change In Unrealized Gain Loss On Available For Sale Marketable Securities ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities	960000	usd
CY2022	dmtk	Change In Unrealized Gain Loss On Available For Sale Marketable Securities ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities	-650000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	200000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-423900000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36700000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	19100000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-100900000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-77000000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	Use of EstimatesThe preparation of consolidated financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the amounts of revenues and expenses reported during the period. On an ongoing basis, management evaluates these estimates and judgments, including but not limited to, those related to test revenue, stock-based compensation, short-term marketable securities, accounts receivable, warrant liability, right-of-use (“ROU”) assets and the realization of deferred tax assets. Actual results may differ from those estimates.
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2022	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit RiskFinancial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and available-for-sale marketable securities. The Company invests its cash balances in major financial institutions that it believes have high credit quality and are insured with the Federal Deposit Insurance Corporation (“FDIC”). At times throughout the year, cash deposits might exceed FDIC insurance limits. The Company has not experienced any losses and does not believe it is exposed to any significant credit risk.
CY2023	dmtk	Number Of Revenue Streams NumberOfRevenueStreams	2	revenuestream
CY2023	dmtk	Revenue Performance Obligation Satisfied Variable Consideration Update Increase Decrease In Revenue RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue	-1200000	usd
CY2022	dmtk	Revenue Performance Obligation Satisfied Variable Consideration Update Increase Decrease In Revenue RevenuePerformanceObligationSatisfiedVariableConsiderationUpdateIncreaseDecreaseInRevenue	-1800000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15296000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14518000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	100000	usd
CY2022	us-gaap	Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract	1000000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4890000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5547000	shares
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Reclassifications<div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation in the consolidated financial statements and accompanying notes to the consolidated financial statements.</span></div>
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	18965000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	208000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	50000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	19123000	usd
CY2023Q4	dmtk	Estimated Market Value Of Debt Securities With Contractual Maturities Of Less Than12 Months EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months	19100000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	49211000	usd
CY2022Q4	dmtk	Estimated Market Value Of Remaining Debt Securities With Contractual Maturities Of Up To23 Months EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months	8200000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	2587000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	9000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	5566000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	41000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	8153000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	50000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	17440000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	301000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	25521000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	511000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	42961000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	812000	usd
CY2023Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	1719000	usd
CY2022Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	3207000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	581000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	733000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2300000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3940000	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	6100000	usd
CY2022Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	6250000	usd
CY2023Q4	dmtk	Computer Equipment Gross ComputerEquipmentGross	831000	usd
CY2022Q4	dmtk	Computer Equipment Gross ComputerEquipmentGross	872000	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	1248000	usd
CY2022Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	913000	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	604000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1344000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8783000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9379000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3795000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3004000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4988000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6375000	usd
CY2023	us-gaap	Depreciation Depreciation	1800000	usd
CY2022	us-gaap	Depreciation Depreciation	1600000	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-18000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-324000	usd
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3534000	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3257000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3130000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	4637000	usd
CY2023Q4	dmtk	Accrued Consulting Services Current AccruedConsultingServicesCurrent	262000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	6650	shares
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	7352	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18565000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18934000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	18100000	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M9D
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	3000000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.045
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.040
CY2023	dmtk	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems	-0.038
CY2022	dmtk	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems	-0.016
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.008
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.004
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.003
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.001
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.222
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.237
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	87436000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	67791000	usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	4303000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3129000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3227000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3849000	usd
CY2023Q4	dmtk	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	13825000	usd
CY2022Q4	dmtk	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	14091000	usd
CY2023Q4	dmtk	Deferred Tax Assets Research And Experimental DeferredTaxAssetsResearchAndExperimental	6234000	usd
CY2022Q4	dmtk	Deferred Tax Assets Research And Experimental DeferredTaxAssetsResearchAndExperimental	4371000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	32000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	28000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	745000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1163000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	115802000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	94422000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	204000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	55000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	13161000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	14178000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	13365000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	14233000	usd
CY2023Q4	dmtk	Deferred Tax Assets Liabilities Before Valuation Allowance DeferredTaxAssetsLiabilitiesBeforeValuationAllowance	102437000	usd
CY2022Q4	dmtk	Deferred Tax Assets Liabilities Before Valuation Allowance DeferredTaxAssetsLiabilitiesBeforeValuationAllowance	80189000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	102437000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	80189000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits		usd
CY2023	dmtk	Percentage Of Useful Lives Of Assets PercentageOfUsefulLivesOfAssets	0.75
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	200000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	200000	usd
CY2023Q4	dmtk	Finance Lease Liability To Be Paid Net Of Fair Value Discount FinanceLeaseLiabilityToBePaidNetOfFairValueDiscount	60000	usd
CY2022Q4	dmtk	Finance Lease Liability To Be Paid Net Of Fair Value Discount FinanceLeaseLiabilityToBePaidNetOfFairValueDiscount	180000	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	5000	usd
CY2022Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	11000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	55000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	169000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	116000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	38000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	53000	usd
CY2023Q4	dmtk	Number Of Improvement Phases NumberOfImprovementPhases	4	phase
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	34100000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	32100000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	8700000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	4672000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	1025000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	869000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	192000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	0	usd
CY2023	us-gaap	Lease Cost LeaseCost	9533000	usd
CY2022	us-gaap	Lease Cost LeaseCost	5541000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	85000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	83000	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	5000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	13000	usd
CY2023	dmtk	Finance Lease Cost FinanceLeaseCost	90000	usd
CY2022	dmtk	Finance Lease Cost FinanceLeaseCost	96000	usd
CY2023Q4	us-gaap	Net Rentable Area NetRentableArea	1802	sqft
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	5609000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	4356000	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	5000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	13000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	114000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	137000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	51089000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	48000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y4M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y4M28D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y1M6D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M10D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0872
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0867
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0625
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0584
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	7569000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	19000	usd
CY2023Q4	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	7588000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	7778000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	19000	usd
CY2023Q4	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	7797000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8000000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	18000	usd
CY2023Q4	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	8018000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8228000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	4000	usd
CY2023Q4	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	8232000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	8464000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0	usd
CY2023Q4	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	8464000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	40362000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q4	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	40362000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	80401000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	60000	usd
CY2023Q4	us-gaap	Contractual Obligation ContractualObligation	80461000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	26062000	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	5000	usd
CY2023Q4	dmtk	Contractual Obligation Undiscounted Excess Amount ContractualObligationUndiscountedExcessAmount	26067000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	54339000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	55000	usd
CY2023Q4	dmtk	Contractual Obligation Liability ContractualObligationLiability	54394000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3069000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	17000	usd
CY2023Q4	dmtk	Contractual Obligation Liability Current ContractualObligationLiabilityCurrent	3086000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	51270000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	38000	usd
CY2023Q4	dmtk	Contractual Obligation Liability Noncurrent ContractualObligationLiabilityNoncurrent	51308000	usd
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1500000	usd

Files In Submission

Name	View Source	Status
0001651944-24-000014-index-headers.html	Edgar Link	pending
0001651944-24-000014-index.html	Edgar Link	pending
0001651944-24-000014.txt	Edgar Link	pending
0001651944-24-000014-xbrl.zip	Edgar Link	pending
dmtk-20231231.htm	Edgar Link	pending
dmtk-20231231.xsd	Edgar Link	pending
dmtk-20231231xex311.htm	Edgar Link	pending
dmtk-20231231xex312.htm	Edgar Link	pending
dmtk-20231231xex321.htm	Edgar Link	pending
dmtk-20231231_g1.jpg	Edgar Link	pending
dmtk-20231231_g2.jpg	Edgar Link	pending
dmtk-20231231_g3.jpg	Edgar Link	pending
dmtk-20231231_g4.jpg	Edgar Link	pending
dmtk-20231231_g5.jpg	Edgar Link	pending
ex1045claudiaibarraseparat.htm	Edgar Link	pending
ex231consent_2023.htm	Edgar Link	pending
ex412.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
dmtk-20231231_def.xml	Edgar Link	unprocessable
dmtk-20231231_lab.xml	Edgar Link	unprocessable
dmtk-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
dmtk-20231231_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
dmtk-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DMTKQ
DermTech Inc Stock $dmtkq

2024 Q1 Form 10-K Financial Statement

#000165194424000014 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DMTKQ DermTech Inc Stock $dmtkq

2024 Q1 Form 10-K Financial Statement

#000165194424000014 Filed on February 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DMTKQ
DermTech Inc Stock $dmtkq